Fox Chase Cancer Center and Ben-Gurion University Honor International Partnership
PHILADELPHIA (Jan. 14, 2008)—Fox Chase Cancer Center and Ben-Gurion University of the Negev (BGU) celebrated their official affiliation with the signing of an agreement Thursday, January 10, at Fox Chase Cancer Center.
The affiliation agreement honors the international partnership that Fox Chase and BGU entered into five years ago. The goals of the partnership are to explore genetic risks of cancer and to incorporate these factors into clinical practice across different cultural settings.
"We at Ben-Gurion University, together with Fox Chase, are certainly involved in helping mankind and human society," said Jimmy Weinblatt, PhD, rector of Ben-Gurion University. "We are plowing our land and seeding together. I'm sure that together we will harvest."
Over the past five years, the two institutions have worked together to establish many cancer-related collaborative programs, such as defining what role viruses play in human cancers and understanding the basis for cancer progression. The partnership also allows postdoctoral students from BGU to spend time at Fox Chase working on research projects.
Ben-Gurion University of the Negev is a world-renowned institute of research and higher learning with campuses in Israel's southern desert in Beer-Sheva, Sede Boqer and Eilat. BGU is a university with a conscience, where the highest academic standards are integrated with community involvement and where the pioneering spirit of discovery flourishes, fulfilling David Ben-Gurion's dream to make the desert bloom.
Founded in 1972, the coming year marks the university's 36th year of support by the American Associates, Ben-Gurion University of the Negev (AABGU). AABGU is a partner in the University's mission to develop the Negev and build a world-class institution of research and education.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.